Next Quarterly Earnings
After-hours — after the market close (typically after 5:30 p.m. CET).
Prothena is an Ireland-based biotechnology company specializing in the development of novel therapies for rare diseases. Through innovative protein immunotherapy, Prothena focuses on effectively treating a range of complex neurological and systemic diseases to improve patient outcomes.
After-hours — after the market close (typically after 5:30 p.m. CET).
Prothena is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — after the market close (typically after 5:30 p.m. CET).
Prothena last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.36 USD.
Prothena has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.